- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 162.23M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $291.8M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $292.43M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $3M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $3M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $179.09M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $179.18M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $108.08M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $146.09M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $476.73M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $516.45M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $300.18M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $310.85M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.56B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.58B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 159.52M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $619K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $4.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.05B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.05B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $22.98M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $12M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$4.68M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.29M |
| Revenue | Q1 2025 · Mar 31, 2024 | $96.65M |